tirzepatide risk and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management How Tirzepatide Supports Cardiovascular Health

The trial involved 1879 patients with inadequate glycemic control on metformin monotherapy, who were randomly assigned to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg, or semaglutide at a dose of 1 mg.After 40 weeks of treatment, all doses of tirzepatide were found to be noninferior and superior to semaglutide in terms of reducing glycated hemoglobin (HbA1c) levels

The autonomous ride-hailing service is coming to San Diego next year

Lancet 140-6736(23): 1053-X

Mounjaro 15 mg is the highest available dose of Tirzepatide, a dual GIP/GLP-1 receptor agonist delivered as a once-weekly pre-filled injection pen

Tirzepatide is a GIP/GLP-1 agonist

Step 1: Check your insurance